Precision Biosciences (DTIL) Equity Income (2022 - 2025)
Precision Biosciences' Equity Income was -$5.37 million in fiscal Q4 2025 (quarter ended Dec 31, 2025), compared with -$972,000 a year earlier.
Analysis
Precision Biosciences (DTIL) Equity Income (2022 - 2025) Analysis & Trends
For FY2025 (ended Dec 31, 2025), Equity Income at Precision Biosciences came in at -$5.28 million.
- In earlier fiscal years, Equity Income was -$1.08 million in FY2024, -$4.93 million in FY2023, -$1.58 million in FY2022 and $184,000 in FY2021.
- The fiscal Q4 2025 figure marks the lowest quarterly Equity Income in data going back to fiscal Q1 2022.
- Per Business Quant data, DTIL's Equity Income in the three fiscal quarters before Q4 2025 was -$591,000 (Q3 2025), -$665,000 (Q2 2025) and $1.34 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -10.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Precision Biosciences | 165.47 Mn | -183.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -5.37 Mn |
| Sep 30, 2025 | -591,000.00 |
| Jun 30, 2025 | -665,000.00 |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | -972,000.00 |
| Sep 30, 2024 | -875,000.00 |
| Jun 30, 2024 | -950,000.00 |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | -871,000.00 |
| Sep 30, 2023 | -1.35 Mn |
| Jun 30, 2023 | -1.37 Mn |
| Mar 31, 2023 | -1.34 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Sep 30, 2022 | -1.78 Mn |
| Jun 30, 2022 | -1.45 Mn |
| Mar 31, 2022 | -952,000.00 |
API Access
Precision Biosciences Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=DTIL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "DTIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=DTIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();